Autopsy report · NCT02841969
Management of the Diabetic Foot Using Electrolysed Water
Cause of deathStaffing, sites or logistics, also regulatory or ethics
“Following consultation, neutral electrolysed water was deemed to be a medical device. A study amendment will re-submitted to NHS Ethics and the UK regulator (MHRA). These actions delayed due to the pandemic - expected to take place in June 2022.”
Life of this trial
- Registered 7 months before it started.
- Suspended: paused, and may or may not restart.
- 200 participants planned (an estimate, not an actual count).
Vital statistics
- Status
- Suspended
- Phase
- Na
- Sponsor
- NHS Lanarkshire
- Sponsor type
- Government (non-US federal)
- Conditions
- Diabetic Foot
- Interventions
- Electrolysed water; Prontosan
- Participants
- 200 (planned, not actual)
- Sites
- 1
- Countries
- United Kingdom
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.